Recordati Industria Chimica e Farmaceutica S.p.A. (LON:0KBS)
London
· Delayed Price · Currency is GBP · Price in EUR 48.30
-0.06 (-0.12%)
At close: Apr 22, 2025
LON:0KBS Revenue
In the year 2024, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.34B EUR with 12.45% growth. Recordati Industria Chimica e Farmaceutica had revenue of 598.48M in the quarter ending December 31, 2024, with 13.75% growth.
Revenue
2.34B EUR
Revenue Growth
+12.45%
P/S Ratio
4.47
Revenue / Employee
510.92K EUR
Employees
4,583
Market Cap
8.65B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.34B | 259.23M | 12.45% |
| Dec 31, 2023 | 2.08B | 229.02M | 12.36% |
| Dec 31, 2022 | 1.85B | 273.23M | 17.29% |
| Dec 31, 2021 | 1.58B | 131.21M | 9.06% |
| Dec 31, 2020 | 1.45B | -32.98M | -2.23% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| HSBC Holdings | 48.93B |
| Shell | 227.10B |
| Unilever | 50.25B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |
| British American Tobacco p.l.c. | 25.87B |
| Rolls-Royce Holdings | 18.91B |